| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 27.206 | 71.628 | 303.864 | 337.590 | 324.022 |
| Total Income - EUR | - | - | - | - | 813 | 51.484 | 100.381 | 359.427 | 409.742 | 358.103 |
| Total Expenses - EUR | - | - | - | - | 2.338 | 74.358 | 117.518 | 379.483 | 443.694 | 394.555 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.526 | -22.873 | -17.137 | -20.056 | -33.952 | -36.452 |
| Net Profit/Loss - EUR | - | - | - | - | -1.526 | -22.965 | -17.655 | -22.835 | -37.166 | -36.452 |
| Employees | - | - | - | - | 0 | 5 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Danials Bioconcept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 33.573 | 34.586 | 27.827 | 22.452 | 17.356 | 29.459 |
| Current Assets | - | - | - | - | 44.024 | 12.443 | 15.271 | 55.120 | 69.245 | 52.711 |
| Inventories | - | - | - | - | 1.893 | 11.054 | 12.357 | 33.694 | 49.083 | 46.420 |
| Receivables | - | - | - | - | 42.089 | 1.116 | 2.551 | 15.576 | 5.283 | 5.904 |
| Cash | - | - | - | - | 42 | 273 | 363 | 5.849 | 14.880 | 387 |
| Shareholders Funds | - | - | - | - | -1.484 | -24.420 | -41.534 | -64.497 | -101.468 | -137.353 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 37.804 | 38.529 | 61.457 | 123.351 | 173.590 | 208.884 |
| Income in Advance | - | - | - | - | 41.276 | 32.919 | 23.175 | 18.718 | 14.478 | 10.903 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1051 - 1051" | |||||||||
| CAEN Financial Year |
1051
|
|||||||||
Comments - Danials Bioconcept S.r.l.